# Elucidating and Directing Heteromolecular Mechanobiology with Nanoengineered Cell Interfaces

> **NIH NIH R35** · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 2024 · $408,258

## Abstract

PROJECT SUMMARY/ABSTRACT
Despite recent progresses in mechanobiology research, there is still a fundamental knowledge gap in critical
cellular functions and molecular mechanisms, which take place between the molecular and cellular scale. For
systematic, quantitative and deterministic studies, there are key challenges to achieve single-molecule precision,
heteromolecular control, simultaneous and independent modulation of multiple physicochemical cues. Based on
our unique approach combining top-down nanotechnology and bottom-up synthetic biology, we will overcome
these challenges and create “smart” cell interfaces which could probe, sense and manipulate cells and the
microenvironment, in an unparalleled precise and controllable manner. The overarching goal of my laboratory is
to bring molecular insights into cell biology, and advance the knowledge of cell as a machine, whose behaviors
and functions can be predicted and directed.
Based on our discoveries in geometric underpinning of molecular mechanobiology, we will address three
outstanding questions: (i) What underlies the spatial effects in receptor clustering, and how are they force-
mediated? (ii) Are there heteromolecular spatial effects in co-clustering and segregation of different receptors,
and what are their roles in signaling crosstalk and integration? (iii) How to use the new knowledge in molecular
mechanisms and effectively direct cell functions? Considering the interplay and crosstalk between multiple
receptors and physicochemical cues, we will reveal the underlying synergistic mechanisms of heteromolecular
mechanobiology for cell-extracellular matrix (ECM) signaling (fibroblast as a model) and cell-cell signaling (T cell
as a model). Specifically, for cell-ECM signaling, we will investigate the integrin clustering mechanism, its
relationship with cellular contractility, and the crosstalk between growth factor receptors and integrins. For cell-
cell juxtacrine signaling, we will investigate the synergistic mechanism of mechanosensing and spatial sensing
in T cell receptor clustering and triggering, and the heteromolecular co-clustering mechanism between activatory
and inhibitory receptors. Finally, the artificial ECM and artificial cell surfaces we developed in this research will
be used to direct critical cell functions for in vitro cell engineering and manufacturing, as well as potential in vivo
applications.
Overall, our technology will break the limit of mechanobiology study with a single type of bioligands on 2D, rigid,
static surfaces, provide heteromolecular control over multiple ligands in a 3D, soft, dynamic fashion, and
therefore better mimic the complex in vivo environment. This transformative methodology can be customized
and adopted in distinct systems to expand our understanding of fundamental molecular and cellular mechanisms,
and apply the new knowledge for novel diagnostic and therapeutic methods.

## Key facts

- **NIH application ID:** 10914781
- **Project number:** 5R35GM147406-03
- **Recipient organization:** NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- **Principal Investigator:** Haogang Cai
- **Activity code:** R35 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $408,258
- **Award type:** 5
- **Project period:** 2022-09-12 → 2027-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10914781

## Citation

> US National Institutes of Health, RePORTER application 10914781, Elucidating and Directing Heteromolecular Mechanobiology with Nanoengineered Cell Interfaces (5R35GM147406-03). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10914781. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*